Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Reneo Receives EMA Orphan Drug Designations for Treatment of LCHAD Deficiency

americanpharmaceuticalreviewSeptember 16, 2020

Tag: Reneo , LCHAD , PMM , FAOD , REN001

PharmaSources Customer Service